International — Total Revenues
Bristol-Myers Squibb International — Total Revenues increased by 3.5% to $3.60B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.3%, from $3.39B to $3.60B. Over 2 years (FY 2022 to FY 2024), International — Total Revenues shows relatively stable performance with a -1.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration or expansion in global regions, while a decrease may signal competitive pressure, pricing challenges, or unfavorable currency exchange impacts in international territories.
Detailed definition
This metric represents the total net sales generated from pharmaceutical products sold outside of the company's primary...
Peer comparison
Peer pharmaceutical companies typically report international revenue as a percentage of total sales to demonstrate geographic diversification; a lower ratio relative to peers suggests higher concentration risk in the domestic market.
bmy_segment_international_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.12B | $4.05B | $3.73B | $3.43B | $3.06B | $3.28B | $3.15B | $3.16B | $3.15B | $3.29B | $3.19B | $3.22B | $3.39B | $3.40B | $3.11B | $3.48B | $3.60B |
| QoQ Change | — | -1.7% | -8.0% | -8.0% | -10.7% | +7.2% | -4.0% | +0.3% | -0.2% | +4.3% | -3.0% | +1.1% | +5.1% | +0.2% | -8.4% | +11.9% | +3.5% |
| YoY Change | — | — | — | -16.9% | -24.4% | — | -15.5% | -7.8% | +3.0% | +0.3% | +1.3% | +2.0% | +7.5% | +3.2% | -2.5% | +8.0% | +6.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's international — total revenues?
- Bristol-Myers Squibb (BMY) reported international — total revenues of $3.60B in Q3 2025.
- How has Bristol-Myers Squibb's international — total revenues changed year-over-year?
- Bristol-Myers Squibb's international — total revenues increased by 6.3% year-over-year, from $3.39B to $3.60B.
- What is the long-term trend for Bristol-Myers Squibb's international — total revenues?
- Over 2 years (2022 to 2024), Bristol-Myers Squibb's international — total revenues has grown at a -1.1% compound annual growth rate (CAGR), from $13.50B to $13.20B.
- What does international — total revenues mean?
- The total revenue generated from sales of products in all countries outside the company's home market.